Urogen Pharma (URGN)
NASDAQ:URGN
Want to see URGN full AI Analyst Report?
Urogen Pharma (URGN) Ownership Overview
1.93% Insiders
6.13% Mutual Funds
52.66% Other Institutional Investors
6.08% ETFs
33.19% Public Companies and
Individual Investors
The ownership structure of Urogen Pharma (URGN) stock is a mix of institutional, retail, and individual investors. Approximately 64.88% of the company’s stock is owned by Institutional Investors, 1.93% is owned by Insiders, and 33.19% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 04, 2026 | xxxxxxxxxxxxx | $145174 | |
Aug 13, 2025 | xxxxxxxxxxxxx | $176900 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $623924 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $2077499 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,769,772 | Institution | 3.63% | 51,128,713 | |
| 918,067 | Institution | 1.88% | 26,522,956 | |
| 500,726 | Institution | 1.03% | 14,465,974 | |
| 495,606 | Institution | 1.02% | 14,318,057 | |
| 459,055 | Institution | 0.94% | 13,262,099 | |
| 408,693 | Insider | 0.84% | 11,807,141 | |
| 386,778 | Institution | 0.79% | 11,174,016 | |
| 376,661 | Institution | 0.77% | 10,881,736 | |
| 343,389 | Institution | 0.70% | 9,920,508 | |
| 326,691 | Insider | 0.67% | 9,438,103 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 918,067 | Institution | 1.88% | 26,522,956 | |
| 459,055 | Institution | 0.94% | 13,262,099 | |
| 386,778 | Institution | 0.79% | 11,174,016 | |
| 343,389 | Institution | 0.70% | 9,920,508 | |
| 146,990 | Institution | 0.30% | 4,246,541 | |
| 118,186 | Institution | 0.24% | 3,414,394 | |
| 115,523 | Institution | 0.24% | 3,337,459 | |
| 108,843 | Institution | 0.22% | 3,144,474 | |
| 92,483 | Institution | 0.19% | 2,671,834 | |
| 60,166 | Institution | 0.12% | 1,738,196 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 939,505 | Institution | 1.93% | 27,997,249 | |
| 282,207 | Institution | 0.58% | 8,409,769 | |
| 272,319 | Institution | 0.56% | 8,115,106 | |
| 198,150 | Institution | 0.41% | 3,562,737 | |
| 184,678 | Institution | 0.38% | 5,785,962 | |
| 166,439 | Institution | 0.34% | 5,214,534 | |
| 117,713 | Institution | 0.24% | 2,116,480 | |
| 103,258 | Institution | 0.21% | 3,077,088 | |
| 101,508 | Institution | 0.21% | 3,024,938 | |
| 73,326 | Institution | 0.15% | 2,297,304 |
FAQ
Who Owns Urogen Pharma (URGN)?
According to the latest TipRanks data, approximately 52.66% of the company's stock is held by institutional investors, 1.93% is held by insiders, and 33.19% is held by retail investors.
What percentage of Urogen Pharma (URGN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 52.66% of Urogen Pharma (URGN) stock is held by institutional investors.
What percentage of Urogen Pharma (URGN) stock is held by retail investors?
According to the latest TipRanks data, approximately 33.19% of Urogen Pharma (URGN) stock is held by retail investors.
Who owns the most shares of Urogen Pharma (URGN)?
iShares owns the most shares of Urogen Pharma (URGN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.